BusinessCantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliXBy Nasdaq OMXApr 12, 2016, 4:00 PM UTC